Top Markets
#1 Islamic Coin Islamic Coin +155.97%
#2 Siren Siren +37.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.25%
#4 Verus Coin Verus Coin +22.40%
#5 Cysic Cysic +19.84%
#6 Arowana Arowana +19.40%
#7 OpenEden OpenEden +17.23%
#8 Perle Perle +14.78%
#9 Ocean Protocol Ocean Protocol +13.13%
#10 RedStone RedStone +12.61%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Endymed Ltd Endymed Ltd

Endymed Ltd

ENDY
Rang in Aktien #31811
Endymed Ltd is a medical technology company focused on the global design,... Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.
Aktienkurs
$0.90225185
Zuletzt synchronisiert: 2025-02-16
Marktkapitalisierung
$11.99M
Veränderung (1 Tag)
0.48%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Endymed Ltd (ENDY)

Kategorie

Healthcare
P/B-Verhältnis für Endymed Ltd (ENDY)
P/B-Verhältnis zum August 2026 TTM: 0.98
Laut den neuesten Finanzberichten und dem Aktienkurs von Endymed Ltd beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0.98. Am Ende des Jahres 2022 lag das P/B-Verhältnis bei 0.70.
P/B-Verlauf für Endymed Ltd von 2013 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) 0.98 27.27%
2023 0.77 9.21%
2022 0.70 -69.49%
2021 2.30 61.09%
2020 1.43 49.52%
2019 0.95 -5.86%
2018 1.01 -82.25%
2017 5.71 70.04%
2016 3.36 -22.26%
2015 4.32 62.06%
2014 2.67 -41.80%
2013 4.58 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.7944 287.18%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.423 453.37%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 2.0146 105.57%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 3.072 213.47%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 4.9725 407.40%
US